Development of PARP Inhibitors in Targeting Castration-Resistant Prostate Cancer
{{output}}
Prostate cancer is a genetically heterogenous disease and a subset of prostate tumors harbor alterations in DNA damage and repair (DDR) genes. Prostate tumor DDR gene alterations can arise via germline or somatic events and are enriched in high-grade and advan... ...